Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-25-062168)

Filing Details

Accession Number:: 0001104659-25-062168
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-24 17:14:35
Reporting Period:: 2025-06-20

Filing Date:: 2025-06-24
Accepted Time:: 2025-06-24 17:14:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1875558	Nuvectis Pharma Inc.	NVCT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1806384	Charles Marlio Mosseri	27 Ripplevale Grove London N1 1HS		No	No	Yes	No

Transaction Summary

Purchased:	5,603 shares	Avg. Price: $7.99	Total Value: $44,767.97
Number of Shares After Transactions:	2,981,806 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-06-20	5,603	$7.99	2,981,806	No	4	P	Indirect	By Emerald Hill Ventures SARL SPF.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Emerald Hill Ventures SARL SPF.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	109,321	Direct

Footnotes

Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.